The following media kits are made available to provide reporters with background information on the range of Medtronic diabetes therapies and the conditions they treat.
Information about the MiniMed™ 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.
Information about the MiniMed™ 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.
Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.1
Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.
1. Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.